CD8A and colorectal neoplasm: In colorectal tumor, pancreatic, and lung tumor models, Allen et al. demonstrated that the GSK3 inhibitor AZD1080-loaded MSNs, termed sAZD1080, reduced the expression of PD-1 in CD8+ T cells and promoted the release of perforin from CD8+ T cells [131].